Abbott India Q3: Revenue Up 7%, Profit Rises 4.2%, Margins Stable

• Abbott India reported a 6.8% year-on-year revenue increase to ₹1,724 crore in Q3 FY25.
• Net profit grew 4.2% to ₹376 crore, up from ₹361 crore in the previous year.
• EBITDA climbed 6.4% to ₹463.8 crore, with EBITDA margin at 26.9%, largely stable.
• Shares of Abbott India were down 1.04% at ₹26,635 on the NSE after the announcement.
• The company maintains a diversified portfolio in gastroenterology, women’s health, cardiology, and more.